Philip Ströbel

495 total citations
9 papers, 291 citations indexed

About

Philip Ströbel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Philip Ströbel has authored 9 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Philip Ströbel's work include Sarcoma Diagnosis and Treatment (4 papers), Soft tissue tumor case studies (3 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Philip Ströbel is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Soft tissue tumor case studies (3 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Philip Ströbel collaborates with scholars based in Germany, United States and Netherlands. Philip Ströbel's co-authors include Robert P. Hasserjian, Marco Niedergethmann, Stefan Post, Alexander Marx, Peter Kienle, Christel Weiß, Claudia Pföhler, Peter J. Mohr, Martin Leverkus and Rüdiger Hein and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal Of Pathology.

In The Last Decade

Philip Ströbel

9 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Ströbel Germany 7 174 158 101 59 39 9 291
Kazuyuki Miyata Japan 9 88 0.5× 162 1.0× 121 1.2× 48 0.8× 34 0.9× 34 327
Laura Antolino Italy 12 143 0.8× 162 1.0× 179 1.8× 62 1.1× 50 1.3× 31 332
Raphael E. Pollock United States 6 128 0.7× 239 1.5× 106 1.0× 149 2.5× 65 1.7× 8 334
Isabelle Sourrouille France 9 244 1.4× 119 0.8× 216 2.1× 25 0.4× 41 1.1× 30 412
Naóe Kinoshita Japan 10 87 0.5× 88 0.6× 135 1.3× 13 0.2× 24 0.6× 52 267
Melissa Vos Netherlands 9 68 0.4× 190 1.2× 51 0.5× 54 0.9× 20 0.5× 15 246
Ali Bohlok Belgium 8 128 0.7× 46 0.3× 112 1.1× 33 0.6× 35 0.9× 32 254
W. H. Hsu Taiwan 13 85 0.5× 227 1.4× 165 1.6× 50 0.8× 89 2.3× 21 402
Richa Jain Canada 8 62 0.4× 123 0.8× 167 1.7× 87 1.5× 17 0.4× 12 319
Kimitaka Miyajima Japan 9 136 0.8× 246 1.6× 67 0.7× 25 0.4× 21 0.5× 13 391

Countries citing papers authored by Philip Ströbel

Since Specialization
Citations

This map shows the geographic impact of Philip Ströbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Ströbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Ströbel more than expected).

Fields of papers citing papers by Philip Ströbel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Ströbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Ströbel. The network helps show where Philip Ströbel may publish in the future.

Co-authorship network of co-authors of Philip Ströbel

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Ströbel. A scholar is included among the top collaborators of Philip Ströbel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Ströbel. Philip Ströbel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Haller, Florian, Fulvia Ferrazzi, Michael Michal, et al.. (2021). Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte Differentiation. American Journal Of Pathology. 191(7). 1314–1324. 6 indexed citations
2.
Fokas, Emmanouil, Rainer Fietkau, Arndt Hartmann, et al.. (2018). Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Annals of Oncology. 29(7). 1521–1527. 53 indexed citations
3.
Fokas, Emmanouil, Maryam Ghadimi, Rainer Fietkau, et al.. (2017). PV-0325: Tumor Regression Grading in the CAO/ARO/AIO-04 phase 3 trial in locally advanced rectal carcinoma. Radiotherapy and Oncology. 123. S170–S171. 1 indexed citations
4.
Agaimy, Abbas, Evgeny A. Moskalev, Johannes Giedl, et al.. (2016). Inactivating Mutations ofRB1andTP53Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors. American Journal of Clinical Pathology. 146(6). 718–726. 25 indexed citations
5.
Ugurel, Selma, Thomas Mentzel, Jochen Utikal, et al.. (2013). Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up. Clinical Cancer Research. 20(2). 499–510. 100 indexed citations
6.
Weiß, Christel, et al.. (2013). Factors Predicting Long-Term Survival Following Pancreatic Resection for Ductal Adenocarcinoma of the Pancreas: 40 Years of Experience. Journal of Gastrointestinal Surgery. 18(4). 674–681. 52 indexed citations
7.
Hohenberger, Peter, Oluwole Solomon Oladeji, Thomas Licht, et al.. (2009). Neoadjuvant imatinib and organ preservation in locally advanced gastrointestinal stromal tumors (GIST). Journal of Clinical Oncology. 27(15_suppl). 10550–10550. 23 indexed citations
8.
Honeck, Patrick, Philip Ströbel, M. Michel, et al.. (2008). Solitärer fibröser Tumor des Hodens (SFT). Aktuelle Urologie. 39(4). 305–308. 3 indexed citations
9.
Hasserjian, Robert P., Philip Ströbel, & Alexander Marx. (2005). Pathology of thymic tumors. Seminars in Thoracic and Cardiovascular Surgery. 17(1). 2–11. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuyuki Miyata Breakdown of academic impact, for papers by Laura Antolino Breakdown of academic impact, for papers by Raphael E. Pollock Breakdown of academic impact, for papers by Isabelle Sourrouille Breakdown of academic impact, for papers by Naóe Kinoshita Breakdown of academic impact, for papers by Melissa Vos Breakdown of academic impact, for papers by Ali Bohlok Breakdown of academic impact, for papers by W. H. Hsu Breakdown of academic impact, for papers by Richa Jain Breakdown of academic impact, for papers by Kimitaka Miyajima
Rankless by CCL
2026